Prediction of treatment response to 72 weeks of pegylated interferon alfa-2a plus ribavirin for chronic hepatitis C after liver transplantation.

被引：0
|
作者：
Neumann, Ulf P.
Bergk, A.
Bahra, Marcus
Thomas, Berg
Neuhaus, Peter
机构：
[1] Virchow Clin, Charite, Dept Surg, Berlin, Germany
[2] Virchow Clin, Charite, Dept Hepatol, Berlin, Germany
来源：
LIVER TRANSPLANTATION | 2007年 / 13卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
370
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [1] Prediction of treatment response to 72 weeks of pegylated interferon alfa-2a plus ribavirin for chronic hepatitis C after liver transplantation.
    Neumann, Ulf P.
    Schmeding, Maximilian
    Bahra, Marcus
    Neuhaus, Ruth
    Bergk, A.
    Berg, Thomas
    Neuhaus, Peter
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 296 - 296
  • [2] Prediction of treatment response to 72 weeks of pegylated interferon alfa-2a plus ribavirin for chronic hepatitis C after liver transplantation
    Bergk, A.
    Neumann, U. P.
    Van Boemmel, F.
    Wiedenmann, B.
    Berg, T.
    Neuhaus, R.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S218 - S219
  • [3] Pegylated interferon ALFA-2A and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, DV
    Weaver, L
    Schafer, DF
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S101 - S101
  • [4] Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4403 - 4405
  • [5] Treatment of chronic hepatitis C with pegylated interferon alfa-2a plus ribavirin in hemophiliac patients
    Malekzadeh, R
    Merat, S
    Sohrabpour, AA
    Khaleghi, S
    Samimi-Rad, K
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A431 - A431
  • [6] Response to Pegylated Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 4
    El Makhzangy, Hesham
    Esmat, Gamal
    Said, Mohamed
    ElRaziky, Maissa
    Shouman, Soheir
    Refai, Rasha
    Rekacewicz, Claire
    Gad, Rita Raafat
    Vignier, Nicolas
    Abdel-Hamid, Mohamed
    Zalata, Khaled
    Bedossa, Pierre
    Pol, Stanislas
    Fontanet, Arnaud
    Mohamed, Mostafa K.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (09) : 1576 - 1583
  • [7] Extrahepatic Manifestations of Chronic Hepatitis C and their Influence on Response to Treatment with Pegylated Interferon Alfa-2a and Ribavirin
    Fabri, Milotka
    Ruzic, Maja
    Lendak, Dajana
    Preveden, Tomislav
    Fabri, Izabella
    Petric, Vedrana
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (5-6) : 320 - 324
  • [8] Pegylated Interferon Alfa-2a Plus Ribavirin in Chronic Hepatitis C Patients with Genotype 6
    Pham, Thuy T.
    Ho, Dat T.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A840 - A840
  • [9] Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin
    Waleed Al-hamoudi
    Hazem Mohamed
    Faisal Abaalkhail
    Yaser Kamel
    Nasser Al-Masri
    Naglaa Allam
    Saleh Alqahtani
    Mohammed Al-Sofayan
    Hatem Khalaf
    Mohammed Al-Sebayel
    Ahmed Al-jedai
    Ayman Abdo
    [J]. Digestive Diseases and Sciences, 2011, 56 : 1848 - 1852
  • [10] Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin
    Al-Hamoudi, Waleed
    Mohamed, Hazem
    Abaalkhail, Faisal
    Kamel, Yaser
    Al-Masri, Nasser
    Allam, Naglaa
    Alqahtani, Saleh
    Al-Sofayan, Mohammed
    Khalaf, Hatem
    Al-Sebayel, Mohammed
    Al-Jedai, Ahmed
    Abdo, Ayman
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (06) : 1848 - 1852
12345